Jane Street Group LLC Buys 374 Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Jane Street Group LLC increased its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 8.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,803 shares of the exchange traded fund’s stock after acquiring an additional 374 shares during the quarter. Jane Street Group LLC’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $306,000 at the end of the most recent quarter.

ProShares Ultra Nasdaq Biotechnology Trading Down 1.1 %

BIB opened at $52.14 on Friday. The company has a 50 day simple moving average of $56.47 and a two-hundred day simple moving average of $61.29. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $47.19 and a 1-year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were issued a dividend of $0.3964 per share. The ex-dividend date of this dividend was Monday, December 23rd. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.